vs
Ultragenyx Pharmaceutical Inc.（RARE）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$225.0M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 24.9%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -12.3%）
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
RARE vs ROCK — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $207.3M | $225.0M |
| 净利润 | $-128.6M | — |
| 毛利率 | — | 25.3% |
| 营业利润率 | -54.7% | 7.9% |
| 净利率 | -62.0% | — |
| 营收同比 | 25.9% | 24.9% |
| 净利润同比 | 3.5% | — |
| 每股收益（稀释后） | $-1.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $207.3M | $225.0M | ||
| Q3 25 | $159.9M | $310.9M | ||
| Q2 25 | $166.5M | $309.5M | ||
| Q1 25 | $139.3M | $290.0M | ||
| Q4 24 | $164.6M | $180.1M | ||
| Q3 24 | $139.5M | $277.1M | ||
| Q2 24 | $147.0M | $273.6M | ||
| Q1 24 | $108.8M | $292.5M |
| Q4 25 | $-128.6M | — | ||
| Q3 25 | $-180.4M | $-89.1M | ||
| Q2 25 | $-115.0M | $26.0M | ||
| Q1 25 | $-151.1M | $21.1M | ||
| Q4 24 | $-133.2M | — | ||
| Q3 24 | $-133.5M | $34.0M | ||
| Q2 24 | $-131.6M | $32.2M | ||
| Q1 24 | $-170.7M | $24.9M |
| Q4 25 | — | 25.3% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 28.9% |
| Q4 25 | -54.7% | 7.9% | ||
| Q3 25 | -106.9% | 12.8% | ||
| Q2 25 | -64.8% | 12.8% | ||
| Q1 25 | -102.6% | 8.8% | ||
| Q4 24 | -74.3% | 13.3% | ||
| Q3 24 | -94.6% | 15.6% | ||
| Q2 24 | -79.1% | 14.9% | ||
| Q1 24 | -151.9% | 10.8% |
| Q4 25 | -62.0% | — | ||
| Q3 25 | -112.8% | -28.6% | ||
| Q2 25 | -69.0% | 8.4% | ||
| Q1 25 | -108.5% | 7.3% | ||
| Q4 24 | -80.9% | — | ||
| Q3 24 | -95.7% | 12.3% | ||
| Q2 24 | -89.5% | 11.8% | ||
| Q1 24 | -156.8% | 8.5% |
| Q4 25 | $-1.28 | — | ||
| Q3 25 | $-1.81 | $-2.98 | ||
| Q2 25 | $-1.17 | $0.87 | ||
| Q1 25 | $-1.57 | — | ||
| Q4 24 | $-1.34 | — | ||
| Q3 24 | $-1.40 | $1.11 | ||
| Q2 24 | $-1.52 | $1.05 | ||
| Q1 24 | $-2.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $421.0M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $-80.0M | $950.4M |
| 总资产 | $1.5B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
| Q4 25 | $421.0M | $115.7M | ||
| Q3 25 | $202.5M | $89.4M | ||
| Q2 25 | $176.3M | $43.3M | ||
| Q1 25 | $127.1M | $25.1M | ||
| Q4 24 | $174.0M | $269.5M | ||
| Q3 24 | $150.6M | $228.9M | ||
| Q2 24 | $480.7M | $179.1M | ||
| Q1 24 | $112.3M | $146.7M |
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $-80.0M | $950.4M | ||
| Q3 25 | $9.2M | $951.8M | ||
| Q2 25 | $151.3M | $1.0B | ||
| Q1 25 | $144.2M | $1.0B | ||
| Q4 24 | $255.0M | $1.0B | ||
| Q3 24 | $346.8M | $1.0B | ||
| Q2 24 | $432.4M | $975.7M | ||
| Q1 24 | $140.3M | $940.2M |
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.6B | $1.4B | ||
| Q1 24 | $1.3B | $1.3B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-99.8M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $-100.8M | $26.2M |
| 自由现金流率自由现金流/营收 | -48.6% | 11.7% |
| 资本支出强度资本支出/营收 | 0.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-472.0M | $120.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-99.8M | $35.5M | ||
| Q3 25 | $-91.4M | $73.0M | ||
| Q2 25 | $-108.3M | $44.9M | ||
| Q1 25 | $-166.5M | $13.7M | ||
| Q4 24 | $-79.3M | $19.9M | ||
| Q3 24 | $-67.0M | $64.7M | ||
| Q2 24 | $-77.0M | $36.5M | ||
| Q1 24 | $-190.7M | $53.2M |
| Q4 25 | $-100.8M | $26.2M | ||
| Q3 25 | $-92.7M | $64.8M | ||
| Q2 25 | $-110.7M | $27.3M | ||
| Q1 25 | $-167.8M | $2.3M | ||
| Q4 24 | $-79.5M | $14.1M | ||
| Q3 24 | $-68.6M | $60.5M | ||
| Q2 24 | $-79.0M | $33.5M | ||
| Q1 24 | $-193.9M | $48.8M |
| Q4 25 | -48.6% | 11.7% | ||
| Q3 25 | -58.0% | 20.8% | ||
| Q2 25 | -66.5% | 8.8% | ||
| Q1 25 | -120.5% | 0.8% | ||
| Q4 24 | -48.3% | 7.8% | ||
| Q3 24 | -49.2% | 21.8% | ||
| Q2 24 | -53.7% | 12.2% | ||
| Q1 24 | -178.2% | 16.7% |
| Q4 25 | 0.5% | 4.1% | ||
| Q3 25 | 0.8% | 2.6% | ||
| Q2 25 | 1.5% | 5.7% | ||
| Q1 25 | 1.0% | 3.9% | ||
| Q4 24 | 0.1% | 3.3% | ||
| Q3 24 | 1.2% | 1.5% | ||
| Q2 24 | 1.4% | 1.1% | ||
| Q1 24 | 3.0% | 1.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
